BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 8, 2015
View Archived Issues
GPR37L1 mutation provides insight for novel inherited neurological disorder
Read More
Study of sASD markers in Taiwanese population provides new data
Read More
Novel approach studied for diagnosis and treatment of DRD
Read More
Novel mutation in a deubiquitinating enzyme related to Diamond Blackfan anemia
Read More
Phase I study begins for MVA-BN Filo/AdVac preventive Ebola vaccine regimen
Read More
Advaxis seeks FDA clearance to study ADXS-HER2 in HER2-expressing solid tumors
Read More
Lion Biotechnologies files IND for phase II study of tumor-infiltrating lymphocytes in melanoma
Read More
FDA responds to Cesca's IDE application for pivotal critical limb ischemia trial
Read More
Kite Pharma to generate CAR T cell therapies against Amgen cancer targets
Read More
Kowa divulges insulin secretagogues
Read More
Taisho Pharmaceutical reports development of GlyT-1 inhibitors
Read More
Seikagaku reports new cathepsin K inhibitors
Read More
CSIPI patents novel platinum complexes
Read More
Janssen discloses new BACE1/2 inhibitors
Read More
European phase III trial of INTERCEPT blood system meets primary endpoint
Read More
cCAM Biotherapeutics cleared to begin phase I trial of CM-24 for cancer
Read More
SGX-94 reduces pancytopenia in animal model of macrophage activation syndrome
Read More
Alkermes reports topline results from phase III study of ALKS-5461 for major depressive disorder
Read More
Dignity Sciences anti-fibrotic shows potential in mouse model of NASH
Read More
Versartis reports data from ongoing extension study of VRS-317 for growth hormone deficiency
Read More
Pfizer's acquires Redvax
Read More
KaloBios reports topline data for phase II study of KB001-A
Read More
Novartis receives approval in Canada for Fluad Pediatric
Read More
Cipher Pharmaceuticals acquires Canadian commercialization rights to ozenoxacin
Read More
Gilead Sciences acquires Phenex Pharmaceuticals' FXR liver disease programs
Read More
FDA grants SGX-301 fast track designation for cutaneous T-cell lymphoma
Read More